Riskpilot← Back to searchSign inGet full accessHalobid Aktiebolag
ABActiveOrg 5564654720Norra Torggatan 15Engineering activities and related technical consultancy · NACE 7112Est. 19930 employees
Revenue 2024
—
EBITDA margin
—
-5% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 100K
-90% vs 2023
| Revenue | — | — |
| EBITDA | SEK -49K | -5% |
| Net profit | SEK 100K | -90% |
| Total assets | SEK 8,4M | +0% |
| Equity | SEK 8,4M | +1% |
| Employees | 0 | — |
Legal name
Halobid Aktiebolag
Org number
5564654720
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
4 maj 1993
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva förvaltning av aktier och andra värdepapper samt därmed förenlig verksamhet.
Address
Norra Torggatan 15
Email
hanna.magnusson@octean.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 | −43 | −44 | −47 | −49 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −1 | −43 | −44 | −47 | −49 |
| Net financials | 2 002 | 1 002 | 1 503 | 1 029 | 149 |
| Profit before tax | 2 001 | 960 | 1 459 | 982 | 100 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | 2 001 | 960 | 1 459 | 982 | 100 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 137 | 9 297 | 8 329 | 8 438 | 8 411 |
| Equity | 7 909 | 7 869 | 8 328 | 8 310 | 8 410 |
| Long-term debt | 1 | 1 | 1 | 1 | 1 |
| Short-term debt | 227 | 1 427 | 0 | 127 | 0 |
| Total debt | 228 | 1 428 | 1 | 128 | 1 |
EBITDA margin
-4947800.0%
This company
15.8%
Market median
-31315290% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
20202024
Net profit margin
9991700.0%
This company
8.1%
Market median
+123354221% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MF Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Halobid Aktiebolag 
Octean Pharma ApsBoard members of Halobid Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Fjellman | Chief Auditor | 0 companies |
| Dan Åke Magnusson | Deputy Board Member | 0 companies |
| Lotte Johannesson | Board of Directors | 0 companies |
| Hanna Magnusson | Chairman | 0 companies |